by Shi-qi An | Aug 19, 2025 | Case Studies
The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) evaluated Amperia RED for AAV2 titre analysis during process development. Results showed strong correlation with their existing automated ELISA system (R² = 0.97). In this case study, we share...
by Shi-qi An | Aug 16, 2025 | Blog
Get to know how Amperia™ fits into your protein quantification workflow. 1. What types of proteins can I measure with Amperia™? Amperia™ is designed for total protein quantification and is compatible with a wide range of analytes, including monoclonal antibodies...
by Shi-qi An | Apr 24, 2025 | News
NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia™ system to streamline viral vector process development for novel gene therapies The NHSBT Clinical Biotechnology Centre (CBC), Bristol, one of three government selected Innovation Hubs...
by Shi-qi An | Apr 9, 2025 | News
We’re excited to share that Abselion is featured in the Spring 2025 issue of Innovations in Pharmaceutical Technology (IPT), highlighting the role of our Amperia system in advancing at-line protein quantification for biologics and viral vector development. The article...
by Shi-qi An | Mar 4, 2025 | News
Abselion is delighted to announce the appointment of Kim Orton-Smith as Vice President of Sales & Marketing. Kim brings 19 years of global commercial experience in life sciences, with a track record of turning product innovation into scalable revenues and driving...
